Intrinsiqq
Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc. Insider Trading

HEPA

Compare
Last 12 months

Insiders bought $1.24M on the open market and sold nothing.

Net open-market
+$1.24M
10 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
6 / 0
executives and directors
Last open-market buy
Sep 2026
Sep 29, 2026

Get an email when HEPA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 29
    Danina Fisher
    Director · bought 200,000 at $0.05
    10K
    New position
  • Aug 3
    Gary S. Stetz II
    Director · bought 500,000 at $0.05
    25K
    New position
  • Aug 3
    Gary S. Stetz
    Interim CEO · bought 2,000,000 at $0.05
    100K
    160% of stake
  • Aug 3
    Michael J. Purcell
    Director · bought 2,000,000 at $0.05
    100K
    160% of stake
  • Aug 3
    Sireesh Appajosyula
    Chief Operating Officer · bought 2,000,000 at $0.05
    100K
    160% of stake
  • Aug 3
    Vincent S Lopriore
    Executive Chairman · bought 10,000,000 at avg $0.05
    500K
    49% of stake
  • Apr 21
    Michael J. Purcell
    Director · bought 1,250,000 at $0.04
    50K
    New position
  • Apr 21
    Vincent S Lopriore
    Executive Chairman · bought 6,250,000 at avg $0.04
    250K
    125% of stake
  • Apr 21
    Sireesh Appajosyula
    Director · bought 1,250,000 at $0.04
    50K
    New position
  • Apr 21
    Gary S. Stetz
    Interim CEO · bought 1,250,000 at $0.04
    50K
    New position
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch HEPA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with HEPA

CompareIntrinsic value
SKVISkinvisible Inc.
$0.18+0.00%0
PMHSPolomar Health Services Inc.
$0.15+45.00%30
TCRTAlaunos Therapeutics Inc.
$1.66+4.40%10
PULMPulmatrix Inc.
$1.28-10.21%40
OTLCOncotelic Therapeutics Inc.
$0.01+22.00%10
GTBPGT Biopharma, Inc.
$2.96-6.92%20
DAREDare Bioscience Inc.
$0.41-9.96%10
PTNPalatin Technologies, Inc.
$4.58-7.10%10

Spot a number that looks wrong? Check it in HEPA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing HEPA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.